![Tsvetelina Pencheva Hoang](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Tsvetelina Pencheva Hoang
Technik-/Wissenschafts-/F&E-Leiter bei MARKER THERAPEUTICS, INC.
Vermögen: - $ am 31.05.2024
Aktive Positionen von Tsvetelina Pencheva Hoang
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
MARKER THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 23.10.2018 | - |
Karriereverlauf von Tsvetelina Pencheva Hoang
Ehemalige bekannte Positionen von Tsvetelina Pencheva Hoang
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
BELLICUM PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.12.2015 | 01.07.2018 |
The Phi Beta Kappa Society
![]() The Phi Beta Kappa Society Miscellaneous Commercial ServicesCommercial Services The Phi Beta Kappa Society operates as an organization for liberal arts and science education. The non-profit company is based in Washington. | Corporate Officer/Principal | - | - |
Ausbildung von Tsvetelina Pencheva Hoang
Yale University | Graduate Degree |
The Johns Hopkins University | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 6 |
Operativ
Corporate Officer/Principal | 2 |
Chief Tech/Sci/R&D Officer | 1 |
Graduate Degree | 1 |
Sektoral
Health Technology | 3 |
Consumer Services | 3 |
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
MARKER THERAPEUTICS, INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
Bellicum Pharmaceuticals, Inc.
![]() Bellicum Pharmaceuticals, Inc. BiotechnologyHealth Technology Bellicum Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It focuses on discovering and developing cellular immunotherapies for cancers and orphan inherited blood disorders. The firm uses its proprietary chemical induction of dimerization that controls components of the immune system in real time. Its product candidates include BPX-601, BPX-603, and Rivo-cel (rivogenlecleucel, formerly known as BPX-501). The company was founded by Kevin M. Slawin and David M. Spencer on July 14, 2004 and is headquartered in Houston, TX. | Health Technology |
The Phi Beta Kappa Society
![]() The Phi Beta Kappa Society Miscellaneous Commercial ServicesCommercial Services The Phi Beta Kappa Society operates as an organization for liberal arts and science education. The non-profit company is based in Washington. | Commercial Services |